Individuals with Li-Fraumeni syndrome can become resistant to chemotherapy. The risk of other primary cancers is increased if a germline mutation has occurred. There is evidence that a TP53 genetic mutation can cause a patient to have an increased sensitivity to ionizing radiation. Individuals with germline TP53 mutations should avoid or minimize exposure to diagnostic and therapeutic radiation when possible.